Head of CDMO Business Development in Europe and Japan
Polpharma
About this role
The Head of CDMO Business Development for Europe and Japan at Polpharma is responsible for expanding the company's market presence by establishing relationships with biotech and pharmaceutical clients, promoting advanced API and ADC technologies, and supporting project execution across these regions.
Skills
About Polpharma
polpharma.plPolpharma to największy polski producent leków i substancji farmaceutycznych. Od 90 lat cieszymy się zaufaniem lekarzy, farmaceutów i pacjentów.
Recent company news
European Pharmaceutical ReviewPolpharma Biologics splits into biosimilars and CDMO businesses
Oct 1, 2025
Business WirePolpharma Biologics and MS Pharma Sign Licensing Agreements for Proposed Vedolizumab (PB016), Ocrelizumab (PB018) and Guselkumab (PB019) Biosimilars
Sep 2, 2025
BioPharm InternationalPolpharma Biologics, Fresenius Kabi Enter Licensing Agreement for Proposed Biosimilar to Takeda’s Entyvio
Aug 6, 2025
PR NewswireChime Biologics Partners Polpharma Biologics to Advance Global Biosimilar Development
Apr 16, 2025
Kursiv MediaPolpharma to expand drug production in Kazakhstan
2 weeks ago
About Polpharma
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Polpharma.
More jobs at Polpharma
Similar Jobs
SVP, Head of Japan & South Korea
Authentic Brands Group
Business Developement - CDMO (US/Europe)
Eurofins
Business Development Mgr-CDMO
AQU1000AQUE
Business Development Manager Japan
Eurofins
Director of Business Development (West Cost - Hybrid - Remote)
Afton Scientific
Head of Sales - Japan
strider technologies